WAY 131256
Latest Information Update: 12 Oct 2011
At a glance
- Originator Wyeth
- Class Neuroprotectants; Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 09 Oct 2000 No-Development-Reported for Alzheimer's disease in USA (Unknown route)
- 29 Aug 1997 Preclinical development for Alzheimer's disease in USA (Unknown route)
- 21 Aug 1997 New profile